GTT: Revenues of 57 million euros in Q1 2017 Revenues of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
79
GTT: Revenues of 57 million euros in Q1 2017

Revenues of 57 million euros in Q1 2017

  • New orders in Q1 2017: 4 FSRUs and 1 LNG carrier
  • 6.6% increase in revenues from services
  • 2017 targets confirmed

Paris, April 11, 2017 - GTT (Gaztransport & Technigaz), an engineering company specialised in the design of membrane containment systems for the maritime transportation and storage of liquefied gas, announces its first quarter revenues for 2017.

Key figures for Q1 2017

(in thousands of euros) Q1 2016 Q1 2017 Change
Revenues 58,555 56,872 (2.9%)
       
From royalties 55,360 53,468 (3.4%)
LNG carrier/ethane carrier 49,922 46,647 (6.6%)
FSRU [1] 4,435 6,310 +42.3%
FLNG [2] 633 435 (31.3%)
Onshore storage 192 - nm
Barge 177 76 (57.1%)
From services 3,195 3,404 +6.6%

Philippe Berterottière, Chairman and CEO of GTT, commented: "The first quarter of 2017 saw GTT win four new FSRU orders, reflecting the entry of new importing countries into the LNG market, which confirms the long term growth perspectives on this market. We are pleased to have positioned ourselves at the right time on this activity segment, a real complement to the LNG carrier segment. We continued to prepare for the future by presenting our brand-new dedicated LPG membrane system, GTT MARS TM , at the Gastech conference and exhibition. At financial level, our revenues in the first three months of the year are in line with our expectations and we are carefully monitoring our cost base in order to safeguard our competitiveness."

Business segment performance

First quarter 2017 revenues amounted to €56.9 million, down 2.9% on the first quarter of 2016.

  • Revenues related to royalties stood at €53.5 million, down 3.4%. Royalties related to LNG carriers and ethane carriers decreased by 6.6% to €46.7 million, while those from FSRUs rose 42.3% to €6.3 million. Other royalties, for €0.4 million, derived from FLNGs, and for €0.1 million from the LNG barge.
  • Revenues related to services amounted to €3.4 million, up 6.6 % compared with the first quarter of 2016, mainly generated by maintenance contracts for ships in service, by engineering studies and supplier approvals.

Highlights of the quarter

- Increase in FSRU orders

Anticipating market developments, GTT decided in recent years to design new solutions for the offshore LNG industry, in particular for Floating Storage Regasification Units (FSRUs).

Today, this is a particularly dynamic sector and one that is preferred by the new importing countries for which FSRUs provide a flexible solution and an economical alternative to onshore regasification terminals. The four new orders booked in the first quarter confirm the relevance of this strategy.

- Presentation of our new, dedicated LPG transport containment system

At the Gastech 2017 conference and exhibition, GTT officially launched GTT MARS TM , its new containment system specially designed for transporting LPG, after receiving General Approval from the Lloyd's Register classification society. This innovation is driven by an environment where it is necessary to minimize ship ownership costs. GTT wanted to deliver an optimal response to the expectations of multi-gas ship operators by increasing vessels' operational flexibility and efficiency while guaranteeing high safety levels.

Being lighter and more compact than competing systems, the GTT MARS TM system can be used to design a smaller, more efficient vessel, offering lower fuel consumption and optimised loading capacity.

Order book

Since January 1, 2017, GTT's order book, which then stood at 96 units, has evolved as follows:

  • 1 LNGC order
  • 4 FSRU orders
  • 12 LNG and ethane carrier deliveries
  • 2 FSRU deliveries

As at March 31, 2017, the order book stood at 87 units:

  • 72 LNG and ethane carriers
  • 10 FSRUs [3]
  • 2 FLNGs
  • 2 onshore storage tanks
  • 1 LNG bunker barge

Outlook for 2017

Subject to any significant delays or order cancellations, the Company confirms its targets for 2017, namely: 

  • 2017 revenues in a range of €225-240 million,
  • a net margin ratio above 50% [4] ,
  • a 2017 dividend amount at least equivalent to those of 2015 and 2016, and, for the two subsequent years, a payout ratio of at least 80% of net income available for distribution [5] .

***

Financial agenda

  • Annual General Meeting of Shareholders: May 18, 2017
  • Payment of balance dividend (€1.33 per share) for 2016: May 31, 2017
  • Release of H1 2017 results: July 20, 2017 (after market close)

             

Investor Relations Contacts

information-financiere@gtt.fr / + 33 1 30 23 42 26 / + 33 1 30 23 20 87

Media Relations Contacts

press@gtt.fr / +33 1 30 23 42 24

About GTT GTT (Gaztransport & Technigaz) is an engineering company expert in containment systems with cryogenic membranes used to transport and store liquefied gas, in particular LNG (Liquefied Natural Gas). For over 50 years, GTT has been maintaining reliable relationships with all stakeholders of the gas industry (shipyards, shipowners, gas companies, terminal operators, classification societies). The Company designs and provides technologies which combine operational efficiency and safety, to equip LNG carriers, floating terminals, and multi-gas carriers. GTT also develops solutions dedicated to land storage and to the use of LNG as fuel for the vessel propulsion, as well as a full range of services. GTT is listed on Euronext Paris, Compartment A (ISIN FR0011726835 Euronext Paris: GTT) and is notably included in SBF 120 and MSCI Small Cap indices.

For further information, please see:  www.gtt.fr .

Important notice The French language version of this press release shall prevail. The figures presented here are those customarily used and communicated to the markets by GTT. This message includes forward-looking information and statements. Such statements include financial projections and estimates, the assumptions on which they are based, as well as statements about projects, objectives and expectations regarding future operations, profits, or services, or future performance. Although GTT management believes that these forward-looking statements are reasonable, investors and GTT shareholders should be aware that such forward-looking information and statements are subject to many risks and uncertainties that are generally difficult to predict and beyond the control of GTT, and may cause results and developments to differ significantly from those expressed, implied or predicted in the forward-looking statements or information. Such risks include those explained or identified in the public documents filed by GTT with the French Financial Markets Authority (AMF), including those listed in the "Risk Factors" section of the GTT base document (in French) registered with the AMF on April 27, 2016 under number R.16-028, and the half-yearly financial report released on July 21, 2016. Investors and GTT shareholders should note that if some or all of these risks are realised they may have a significant unfavourable impact on GTT.

[1] Floating Storage Regasification Unit

[2] Floating Liquefied Natural Gas vessel

[3] Includes the conversion of an order for an LNG carrier into one for an FSRU

[4] Excluding potential acquisitions effect and at constant scope

[5] Subject to approval by the Annual General Meeting of Shareholders

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...76ae2bfe4e

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 352

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

YouTube Shuts Down Tenet Media Channel Amid Legal Issues

Updated Category News Views 305

YouTube's Action Against Tenet Media Explained YouTube, which is part of Alphabet (NASDAQ: GOOGL), has made a significant move by shutting down the Tenet Media channel, along with four other channels managed by Lauren Chen. This decision comes in response to serious legal actions taken by the U.S. Department of Justice against certain individuals involved in money...

Continue Reading
Ardelyx Faces Class Action Lawsuit Amidst Investment Losses

Updated Category News Views 112

Important Update for Ardelyx Investors Regarding Class Action Pomerantz LLP has recently informed shareholders about a class action lawsuit involving Ardelyx, Inc. This lawsuit targets both the company and its key officers, alleging violations of federal securities laws. Investors who held Ardelyx securities during a specified timeframe should pay close attention to this...

Continue Reading
Derek Bryson Park: Innovator Transforming Finance Worldwide

Updated Category News Views 205

Celebrating Derek Bryson Park's Impact on Finance Derek Bryson Park has recently been highlighted by The Enterprise World Magazine as a key figure in the financial industry, a well-deserved recognition for his extensive and impactful career. With three decades of experience, Park continues to innovate in finance, public service, and global diplomacy. Pioneering Leadership...

Continue Reading
Understanding Currency Impacts in Global Trade Dynamics

Updated Category News Views 291

Understanding Currency Impacts in Global Trade Dynamics Scott Bessent, a noted figure in finance, is igniting conversations regarding tariffs and trade in recent discussions. All eyes on Wall Street are focused on how these changes influence market dynamics. Initially, any reduction in the U.S. trade deficit with other nations may seem like a significant win for the...

Continue Reading
Pennant Group Expands Its Operations with Recent Acquisition

Updated Category News Views 283

Pennant Group's Strategic Acquisition Announcement The Pennant Group, Inc. (NASDAQ: PNTG), a prominent holding company in the healthcare industry, recently achieved a significant milestone by acquiring specific operational assets from UnitedHealth Group Incorporated. This notable transaction was made possible due to UnitedHealth’s acquisition of Amedisys Inc., enabling...

Continue Reading